The American Journal of Medicine
Volume 123, Issue 7 , Pages 583-592 , July 2010

The Diagnosis of Gastroesophageal Reflux Disease

  • Brian E. Lacy, PhD, MD

      Affiliations

    • Division of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • Corresponding Author InformationReprint requests should be addressed to Brian E. Lacy, PhD, MD, Division of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, 1 Medical Center Drive, Area 4C, Lebanon, NH 03756
    • ,
  • Kirsten Weiser, MD, MPh

      Affiliations

    • Division of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • ,
  • Jocelyn Chertoff, MD, MS

      Affiliations

    • Division of Radiology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • ,
  • Ronnie Fass, MD

      Affiliations

    • Southern Arizona VA Health Care System, Tucson
    • ,
  • John E. Pandolfino, MD

      Affiliations

    • Northwestern University Feinberg School of Medicine, Chicago, Ill
    • ,
  • Joel E. Richter, MD

      Affiliations

    • Temple University School of Medicine, Philadelphia, Pa
    • ,
  • Richard I. Rothstein, MD

      Affiliations

    • Division of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • ,
  • Chad Spangler, MD

      Affiliations

    • Division of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • ,
  • Michael F. Vaezi, MD, PhD, MSc

      Affiliations

    • Vanderbilt University Medical Center, Nashville Tenn

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Funding: None.

 Conflict of Interest: Drs Weiser, Spangler, Vaezi, and Chertoff do not have any potential conflicts of interest to disclose. Dr Lacy has received investigator-initiated, unrestricted funding for clinical research projects from AstraZeneca, Novartis, and Takeda. Dr Fass has received investigator-initiated research funds from AstraZeneca, Wyeth, and Takeda. He serves as a consultant to Takeda, AstraZeneca, Eisai, GlaxoSmithKline, Vecta, Procter & Gamble, Pfizer, Xenoport, and Addex. Dr Richter has served on the speaker's bureaus for AstraZeneca and TAP. Dr Pandolfino has received investigator-initiated research funds from AstraZeneca, Santarus, Medtronics, and Crospon. Dr Rothstein has received investigator-initiated research funds for studies involving the endoscopic treatment of reflux disease from Ethicon, Olympus, and Bard.

 Authorship: All authors had access to the data and played a role in writing this manuscript.

PII: S0002-9343(10)00069-0

doi: 10.1016/j.amjmed.2010.01.007

The American Journal of Medicine
Volume 123, Issue 7 , Pages 583-592 , July 2010

Article Tools

* Image Usage & Resolution